共 178 条
[1]
Raghu G(2011)An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am J Respir Crit Care Med 183 788-824
[2]
Collard HR(2005)Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 1040-1047
[3]
Egan JJ(2010)Pirfenidone in idiopathic pulmonary fibrosis Eur Respir J 35 821-829
[4]
Martinez FJ(2014)INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis N Engl J Med 370 2071-2082
[5]
Behr J(2014)A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis N Engl J Med 370 2083-2092
[6]
Brown KK(2011)Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials Lancet 377 1760-1769
[7]
Azuma A(2005)Idiopathic interstitial pneumonias: CT features Radiology 236 10-21
[8]
Nukiwa T(2010)Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 181 832-837
[9]
Tsuboi E(2008)Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival Am J Respir Crit Care Med 177 433-439
[10]
Suga M(2014)Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis Eur Respir J 43 204-212